LEASE [Phase 3 Properties / Icagen, Inc.] [8,932 SF]Lease • August 14th, 2007 • Icagen Inc • Pharmaceutical preparations • North Carolina
WE HEREBY ISSUE OUR IRREVOCABLE STANDBY LETTER OF CREDIT NO. XXXXXXX ("LETTER OF CREDIT") IN YOUR FAVOR, AVAILABLE FOR PAYMENT BY BANK OF AMERICA, N.A., 1000 W. TEMPLE STREET, 7TH FLOOR, LOS ANGELES, CA 90012, MAIL CODE: CA9-705-07-05, ATTN: STANDBY LETTER OF CREDIT DEPARTMENT OF BENEFICIARY'S DRAFT AT SIGHT DRAWN ON US, AND ACCOMPANIED BY THE FOLLOWING DOCUMEMT(S):
PURCHASE AGREEMENTPurchase Agreement • August 14th, 2007 • Icagen Inc • Pharmaceutical preparations • New York
This PURCHASE AGREEMENT (the “Agreement”) is entered into as of August 13, 2007, by and between ICAGEN, INC., a Delaware corporation having an office at 4222 Emperor Boulevard, Suite 350, Durham, North Carolina 27703 (the “Company”), and PFIZER INC, a Delaware corporation having an office at 235 East 42nd Street, New York, New York (“Pfizer”).
